Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy

Strandberg K, Ayoglu B, Roos A, et al. Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy. Journal of neuromuscular diseases 2020;7:231-246   Abstract BACKGROUND: Duchenne Muscular Dystrophy is a severe, incurable disorder caused by mutations in the dystrophin gene. The disease is characterized by decreased muscle function, impaired muscle regeneration and increased inflammation. […]